Related references
Note: Only part of the references are listed.Natriuretic peptides in human heart: Novel insight into their molecular forms, functions, and diagnostic use
Ayaka Matsuo et al.
PEPTIDES (2019)
Molecular Implications of Natriuretic Peptides in the Protection from Hypertension and Target Organ Damage Development
Speranza Rubattu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
ARNi: A Novel Approach to Counteract Cardiovascular Diseases
Massimo Volpe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations
Christian Mueller et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Angiotensin Receptor Neprilysin Inhibitor Attenuates Myocardial Remodeling and Improves Infarct Perfusion in Experimental Heart Failure
Daniel PFau et al.
SCIENTIFIC REPORTS (2019)
Natriuretic peptides in heart failure: Current achievements and future perspectives
Massimo Volpe et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
PCSK9 is Expressed in Human Visceral Adipose Tissue and Regulated by Insulin and Cardiac Natriuretic Peptides
Marica Bordicchia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF)
James L. Januzzi et al.
AMERICAN HEART JOURNAL (2018)
Endothelial C-Type Natriuretic Peptide Acts on Pericytes to Regulate Microcirculatory Flow and Blood Pressure
Katarina Spiranec et al.
CIRCULATION (2018)
Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
Ulrik M. Mogensen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Natriuretic Peptides in Cardiovascular and Metabolic Crosstalk: Implications for Hypertension Management
Jens Jordan et al.
HYPERTENSION (2018)
The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases
Speranza Rubattu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Sacubitril/Valsartan Averts Adverse Post-Infarction Ventricular Remodeling and Preserves Systolic Function in Rabbits
Juan Torrado et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Identification and functional analysis of CORIN variants in hypertensive patients
Yue Zhang et al.
HUMAN MUTATION (2017)
Endothelium-Derived C-Type Natriuretic Peptide Contributes to Blood Pressure Regulation by Maintaining Endothelial Integrity
Kazuhiro Nakao et al.
HYPERTENSION (2017)
Atrial natriuretic peptide induces peroxisome proliferator activated receptor γ during cardiac ischemia-reperfusion in swine heart
Tomoyuki Suzuki et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2017)
Insulin/glucose induces natriuretic peptide clearance receptor in human adipocytes: a metabolic link with the cardiac natriuretic pathway
M. Bordicchia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2016)
Role of atrial natriuretic peptide in ischemic preconditioning-induced cardioprotection in the diabetic rat heart
Kali Charan et al.
JOURNAL OF SURGICAL RESEARCH (2016)
MOLECULAR PHYSIOLOGY OF MEMBRANE GUANYLYL CYCLASE RECEPTORS
Michaela Kuhn
PHYSIOLOGICAL REVIEWS (2016)
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides
Aldo Clerico et al.
CLINICA CHIMICA ACTA (2015)
PCSK6-mediated corin activation is essential for normal blood pressure
Shenghan Chen et al.
NATURE MEDICINE (2015)
Neprilysin in Heart Failure From Oblivion to Center Stage
Antoni Bayes-Genis
JACC-HEART FAILURE (2015)
Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure
Nicolas Vodovar et al.
JACC-HEART FAILURE (2015)
Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
Milton Packer et al.
CIRCULATION (2015)
Natriuretic peptides in cardiovascular diseases: current use and perspectives
Massimo Volpe et al.
EUROPEAN HEART JOURNAL (2014)
Endothelial C-type natriuretic peptide maintains vascular homeostasis
Amie J. Moyes et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Natriuretic peptides in cardiometabolic regulation and disease
Nora E. Zois et al.
NATURE REVIEWS CARDIOLOGY (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
C2238 Atrial Natriuretic Peptide Molecular Variant Is Associated With Endothelial Damage and Dysfunction Through Natriuretic Peptide Receptor C Signaling
Sebastiano Sciarretta et al.
CIRCULATION RESEARCH (2013)
Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure
Marie-France Seronde et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure: implications for novel therapeutic strategies
Speranza Rubattu et al.
JOURNAL OF HYPERTENSION (2013)
Endothelial actions of atrial and B-type natriuretic peptides
Michaela Kuhn
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients With Stable Coronary Disease
Marc S. Sabatine et al.
CIRCULATION (2012)
Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides
Camilla Calvieri et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Influence of rs5065 Atrial Natriuretic Peptide Gene Variant on Coronary Artery Disease
Emanuele Barbato et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling
Yasuhiro Izumiya et al.
INTERNATIONAL JOURNAL OF VASCULAR MEDICINE (2012)
Natriuretic peptide metabolism, clearance and degradation
Lincoln R. Potter
FEBS JOURNAL (2011)
N-Terminal Pro-Brain Natriuretic Peptide A Powerful Predictor of Mortality in Hypertension
Vinciane Paget et al.
HYPERTENSION (2011)
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
C. M. O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inhibition of TRPC6 Channel Activity Contributes to the Antihypertrophic Effects of Natriuretic Peptides-Guanylyl Cyclase-A Signaling in the Heart
Hideyuki Kinoshita et al.
CIRCULATION RESEARCH (2010)
Decreased Expression of Natriuretic Peptides Associated with Lipid Accumulation in Cardiac Ventricle of Obese Mice
Emil Daniel Bartels et al.
ENDOCRINOLOGY (2010)
NPR-C: a component of the natriuretic peptide family with implications in human diseases
Speranza Rubattu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Experimental investigation of direct myocardial protective effect of atrial natriuretic peptide in cardiac surgery
Shinji Wakui et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2010)
Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons
Lori B. Daniels
CURRENT CARDIOVASCULAR RISK REPORTS (2010)
Dysfunctional Corin I555(P568) Allele Is Associated With Impaired Brain Natriuretic Peptide Processing and Adverse Outcomes in Blacks With Systolic Heart Failure Results From the Genetic Risk Assessment in Heart Failure Substudy
J. Eduardo Rame et al.
CIRCULATION-HEART FAILURE (2009)
The natriuretic peptide/guanylyl cyclase-A system functions as a stress-responsive regulator of angiogenesis in mice
Michaela Kuhn et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro
Stefania Scarpino et al.
JOURNAL OF HYPERTENSION (2009)
Natriuretic peptides: An update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases
Speranza Rubattu et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction
Shu Kasama et al.
EUROPEAN HEART JOURNAL (2008)
Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth
R. Sarzani et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials
Masafumi Kitakaze et al.
LANCET (2007)
Natriuretic peptides and therapeutic applications
Candace Y. W. Lee et al.
HEART FAILURE REVIEWS (2007)
Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue
C. Moro et al.
DIABETOLOGIA (2007)
Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass
Speranza Rubattu et al.
JOURNAL OF HYPERTENSION (2007)
Corin I555(p568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload
J. Eduardo Rame et al.
HYPERTENSION (2007)
Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with first anterior acute myocardial infarction
Shu Kasama et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice
Yong Wang et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes
Adrienne Laskowski et al.
CARDIOVASCULAR RESEARCH (2006)
Structural determinants of natriuretic peptide receptor specificity and degeneracy
Xiao-lin He et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Association of atrial natriuretic peptide and type A natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension
Speranza Rubattu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Novel snake venom ligand dendroaspis natriuretic peptide is selective for natriuretic peptide receptor-A in human heart - Downregulation of natriuretic peptide receptor-A in heart failure
Gurminder Singh et al.
CIRCULATION RESEARCH (2006)
Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts
Xi-Ming Yang et al.
BASIC RESEARCH IN CARDIOLOGY (2006)
Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B
TH Langenickel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications
A Clerico et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice
M Nakanishi et al.
HYPERTENSION (2005)
Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides
T Tokudome et al.
CIRCULATION (2005)
Short-term risk of death after treatment with nesiritide for decompensated heart failure - A pooled analysis of randomized controlled trials
JD Sackner-Bernstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure
JD Sackner-Bernstein et al.
CIRCULATION (2005)
Beneficial effects of PPAR-γ ligands in ischemia-reperfusion injury, inflammation and shock
M Abdelrahman et al.
CARDIOVASCULAR RESEARCH (2005)
C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction
T Socki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Hypertension in mice lacking the proatrial natriuretic peptide convertase corin
JCY Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Brain and other natriuretic peptides: molecular aspects
M Vanderheyden et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-β in primary human cardiac fibroblasts -: Fibrosis, myofibroblast conversion, proliferation, and inflammation
AM Kapoun et al.
CIRCULATION RESEARCH (2004)
Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse
T Mori et al.
CARDIOVASCULAR RESEARCH (2004)
Omapatrilat and enalapril in patients with hypertension: The omapatrilat cardiovascular treatment vs. enalapril (OCTAVE) trial
OB Kostis et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
Metabolic syndrome and target organ damage in untreated essential hypertensives
C Cuspidi et al.
JOURNAL OF HYPERTENSION (2004)
Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1
D Hayashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Atrial natriuretic peptide protects against ischemia-reperfusion injury in the isolated rat heart
K Sangawa et al.
ANNALS OF THORACIC SURGERY (2004)
Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling
V Franco et al.
HYPERTENSION (2004)
Mechanisms of renal hyporesponsiveness to ANP in heart failure
A Charloux et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Role of the natriuretic peptide system in lipogenesis/lipolysis
P Dessi-Fulgheri et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2003)
Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotective effects against ischemia reperfusion in isolated rat hearts
H Okawa et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts
T Horio et al.
ENDOCRINOLOGY (2003)
Increased atherosclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A-/- apolipoprotein E-/- mice
MR Alexander et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Pressure-independent enhancement of cardiac hypertrophy in atrial natriuretic peptide-deficient mice
JA Feng et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2003)
Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro
H Kook et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries
JY Qian et al.
CIRCULATION RESEARCH (2002)
Pharmacological potentiation of natriuretic peptide limits polymorphonuclear neutrophil-vascular cell interactions
EM Mtairag et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Comparison of omapatrilat chronic and enalapril in patients with heart failure - The omapatrilat versus enalapril randomized trial of utility in reducing events (OVERTURE)
M Packer et al.
CIRCULATION (2002)
Induction of IκB:: atrial natriuretic peptide as a regulator of the NF-κB pathway
AK Kiemer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Dietary salt supplementation selectively downregulates NPR-C receptor expression in kidney independently of ANP
JZ Sun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction
M Hayashi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice
JW Knowles et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels
MLH Honing et al.
HYPERTENSION (2001)
A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy
I Kishimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
JL Rouleau et al.
LANCET (2000)
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure.
WS Colucci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Cardiac fibrosis in mice lacking brain natriuretic peptide
N Tamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Functional deletion mutation of the 5′-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese
T Nakayama et al.
CIRCULATION RESEARCH (2000)
Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes
T Horio et al.
HYPERTENSION (2000)
Hypoxia reduces atrial natriuretic peptide clearance receptor gene expression in ANP knockout mice
JZ Sun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2000)
Share Paper
